Syndax Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US87164F1057

SecuritySNDX / Syndax Pharmaceuticals, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in SNDX / Syndax Pharmaceuticals, Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Syndax Pharmaceuticals, Inc. (US:SNDX) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 180,000 shares of Syndax Pharmaceuticals, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 0 -100.00 0
2025-11-13 2025-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 2,769 64.23 0.0032
2025-08-14 2025-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 1,686 -23.74 0.0021
2025-08-14 2025-03-31 13F/A-1 SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 2,211 -7.10 0.0027
2025-05-15 2025-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 2,211 0.0029
2025-02-14 2024-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 -63,352 -26.03 2,380 -49.20 0.0029
2024-11-14 2024-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 243,352 433 0.18 4,685 -6.06 0.0051
2024-08-09 2024-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 242,919 -73 -0.03 4,987 -13.76 0.0057
2024-05-14 2024-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 242,992 -1,098 -0.45 5,783 9.63 0.0066
2024-02-14 2023-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 244,090 11,624 5.00 5,275 56.30 0.0061
2023-11-14 2023-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 232,466 1,023 0.44 3,375 -30.33 0.0042
2023-10-27 2023-06-30 13F/A-2 SYNDAX PHARMACEUTICALS COM 87164F105 231,443 51,443 28.58 4,844 27.41 0.0055
2023-10-12 2023-06-30 13F/A-1 SYNDAX PHARMACEUTICALS COM 87164F105 231,443 51,443 4,844 0.0049
2023-08-14 2023-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 231,443 51,443 4,844 0.0049
2023-06-01 2023-03-31 13F/A-1 SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 3,802 -17.01 0.0045
2023-05-15 2023-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 3,802 0.0035
2023-02-21 2022-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 4,581 5.33 0.0054
2022-11-14 2022-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 -991 -0.55 4,349 24.90 0.0053
2022-08-17 2022-06-30 13F/A-1 SYNDAX PHARMACEUTICALS COM 87164F105 180,991 0 0.00 3,482 10.72 0.0039
2022-08-15 2022-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,991 0 3,482 0.0012
2022-05-16 2022-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,991 0 0.00 3,145 -20.62 0.0024
2022-02-11 2021-12-31 13F Syndax Pharmaceuticals COM 87164F105 180,991 0 0.00 3,962 14.54 0.0033
2021-11-12 2021-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,991 0 0.00 3,459 11.29 0.0029
2021-08-13 2021-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,991 0 0.00 3,108 -23.20 0.0026
2021-05-14 2021-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,991 991 0.55 4,047 1.10 0.0057
2021-02-16 2020-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 4,003 50.66 0.0058
2020-11-13 2020-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 2,657 -0.41 0.0045
2020-08-11 2020-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 2,668 35.09 0.0046
2020-05-15 2020-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 1,975 25.00 0.0041
2020-03-18 2019-12-31 13F/A-2 SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 1,580 17.47 0.0023
2020-02-28 2019-12-31 13F/A-1 SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 1,580 0.0023
2020-02-14 2019-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 1,580 1,982.7661
2019-11-14 2019-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 1,345 -19.75 0.0023
2019-11-06 2019-06-30 13F/A-2 SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 1,676 77.35 0.0028
2019-09-24 2019-06-30 13F/A-1 SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 1,676 0.0029
2019-08-14 2019-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 1,676
2019-05-15 2019-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 945 17.98 0.0016
2019-02-15 2018-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 801 -44.91 0.0015
2018-11-15 2018-09-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 0 0.00 1,454 15.03 0.0024
2019-03-21 2018-06-30 13F/A-1 SYNDAX PHARMACEUTICALS COM 87164F105 180,000 180,000 1,264 0.0022
2018-08-14 2018-06-30 13F SYNDAX PHARMACEUTICALS COM 87164F105 180,000 180,000 1,264
2018-05-11 2018-03-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 0 -1,200 -100.00 0 -100.00
2018-02-14 2017-12-31 13F SYNDAX PHARMACEUTICALS COM 87164F105 1,200 1,200 11 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.